These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 34253930)
81. Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 Treatment. Ghandili S; Schönlein M; Lütgehetmann M; Schulze Zur Wiesch J; Becher H; Bokemeyer C; Sinn M; Weisel KC; Leypoldt LB Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359701 [TBL] [Abstract][Full Text] [Related]
82. Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients. Heudel P; Favier B; Assaad S; Zrounba P; Blay JY Ann Oncol; 2021 Nov; 32(11):1443-1444. PubMed ID: 34333128 [No Abstract] [Full Text] [Related]
83. Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Benjamini O; Rokach L; Itchaki G; Braester A; Shvidel L; Goldschmidt N; Shapira S; Dally N; Avigdor A; Rahav G; Lustig Y; Ben David SS; Fineman R; Paz A; Bairey O; Polliack A; Levy I; Tadmor T Haematologica; 2022 Mar; 107(3):625-634. PubMed ID: 34320789 [TBL] [Abstract][Full Text] [Related]
84. Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients. Del Bello A; Abravanel F; Marion O; Couat C; Esposito L; Lavayssière L; Izopet J; Kamar N Am J Transplant; 2022 Jan; 22(1):322-323. PubMed ID: 34331842 [No Abstract] [Full Text] [Related]
85. COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies. Passamonti F; Romano A; Salvini M; Merli F; Porta MGD; Bruna R; Coviello E; Romano I; Cairoli R; Lemoli R; Farina F; Venditti A; Busca A; Ladetto M; Massaia M; Pinto A; Arcaini L; Tafuri A; Marchesi F; Fracchiolla N; Bocchia M; Armiento D; Candoni A; Krampera M; Luppi M; Cardinali V; Galimberti S; Cattaneo C; La Barbera EO; Mina R; Lanza F; Visani G; Musto P; Petrucci L; Zaja F; Grossi PA; Bertù L; Pagano L; Corradini P; Br J Haematol; 2021 Nov; 195(3):371-377. PubMed ID: 34272724 [TBL] [Abstract][Full Text] [Related]
86. Two Doses of SARS-CoV-2 Vaccines Reduce Risk of Death Due to COVID-19 in Solid Organ Transplant Recipients: Preliminary Outcomes From a UK Registry Linkage Analysis. Ravanan R; Mumford L; Ushiro-Lumb I; Callaghan C; Pettigrew G; Thorburn D; Gardiner D; Forsythe J; Transplantation; 2021 Nov; 105(11):e263-e264. PubMed ID: 34310530 [No Abstract] [Full Text] [Related]
87. Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine. Stumpf J; Siepmann T; Lindner T; Karger C; Schwöbel J; Anders L; Faulhaber-Walter R; Schewe J; Martin H; Schirutschke H; Barnett K; Hüther J; Müller P; Langer T; Pluntke T; Anding-Rost K; Meistring F; Stehr T; Pietzonka A; Escher K; Cerny S; Rothe H; Pistrosch F; Seidel H; Paliege A; Beige J; Bast I; Steglich A; Gembardt F; Kessel F; Kröger H; Arndt P; Sradnick J; Frank K; Klimova A; Mauer R; Grählert X; Anft M; Blazquez-Navarro A; Westhoff TH; Stervbo U; Tonn T; Babel N; Hugo C Lancet Reg Health Eur; 2021 Oct; 9():100178. PubMed ID: 34318288 [TBL] [Abstract][Full Text] [Related]
88. Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients. Aslam S; Adler E; Mekeel K; Little SJ Transpl Infect Dis; 2021 Oct; 23(5):e13705. PubMed ID: 34324256 [TBL] [Abstract][Full Text] [Related]
89. Response to mRNA vaccination for COVID-19 among patients with multiple myeloma. Stampfer SD; Goldwater MS; Jew S; Bujarski S; Regidor B; Daniely D; Chen H; Xu N; Li M; Green T; Fung E; Aquino E; Swift R; Eshaghian S; Preugschat K; Feinstein AJ; Spektor TM; Berenson JR Leukemia; 2021 Dec; 35(12):3534-3541. PubMed ID: 34326466 [TBL] [Abstract][Full Text] [Related]
90. Response to "SARS-CoV-2 vaccine effectiveness trumps immunogenicity in solid organ transplant recipients". Malinis M; Cohen E; Azar MM Am J Transplant; 2021 Dec; 21(12):4106-4107. PubMed ID: 34328268 [No Abstract] [Full Text] [Related]
91. Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept. Chavarot N; Morel A; Leruez-Ville M; Vilain E; Divard G; Burger C; Serris A; Sberro-Soussan R; Martinez F; Amrouche L; Bererhi L; Lanternier F; Legendre C; Zuber J; Anglicheau D; Scemla A Am J Transplant; 2021 Dec; 21(12):4043-4051. PubMed ID: 34431207 [TBL] [Abstract][Full Text] [Related]
92. Scleroderma renal crisis following mRNA vaccination against SARS-CoV-2. Oniszczuk J; Pagot E; Limal N; Hüe S; Audard V; Moktefi A; El Karoui K Kidney Int; 2021 Oct; 100(4):940-941. PubMed ID: 34339745 [No Abstract] [Full Text] [Related]
93. Serological SARS-CoV-2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID-19 vaccine in haematological and oncological patients. Benda M; Mutschlechner B; Ulmer H; Grabher C; Severgnini L; Volgger A; Reimann P; Lang T; Atzl M; Huynh M; Gasser K; Petrausch U; Fraunberger P; Hartmann B; Winder T Br J Haematol; 2021 Nov; 195(4):523-531. PubMed ID: 34346068 [TBL] [Abstract][Full Text] [Related]